| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
H19/IGF2 imprinting control region | 0.631 | 0.615 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
cyclin dependent kinase inhibitor 2C | 0.527 | 0.654 | 0.40 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
KCNQ1 opposite strand/antisense transcript 1 | 0.534 | 0.731 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
potassium voltage-gated channel subfamily Q member 1 | 0.485 | 0.769 | 4.5E-08 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.110 | None | 1.000 | 2 | 2 | 1989 | 2016 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||
|
Ras association domain family member 7 | 0.621 | 0.538 | 2.3E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||
|
Chromosome 11p13 deletion syndrome, distal | 0.861 | 0.231 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1989 | 1989 | |||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 1991 | 2019 | ||||||||
|
TBC1 domain family member 9 | 0.399 | 0.846 | 2.8E-05 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1991 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.800 | strong | 0.960 | 50 | 26 | 1992 | 2017 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 1992 | 1992 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.500 | None | 0.958 | 24 | 0 | 1993 | 2019 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
nuclear receptor subfamily 0 group B member 1 | 0.494 | 0.808 | 0.97 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1995 | 2008 | ||||||||
|
synaptophysin | 0.481 | 0.808 | 0.92 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
chromogranin A | 0.490 | 0.808 | 3.0E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1996 | 2019 | ||||||||
|
steroidogenic acute regulatory protein | 0.513 | 0.808 | 8.8E-11 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 1996 | 2016 | ||||||||
|
sterol carrier protein 2 | 0.644 | 0.500 | 8.7E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
nuclear receptor subfamily 5 group A member 1 | 0.479 | 0.731 | 0.99 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1997 | 2017 |